SCHEMBL113446

SCHEMBL113446

COc1cncc(N)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31162408 1.00
Bromide SCHEMBL4761808 0.98 ALDH1A1 (0.45)
Hydrochloric Acid SCHEMBL3933926 0.98 ALDH1A1 (0.45)
SCHEMBL4441012 0.88 CYP3A4 (0.38)
SCHEMBL744752 0.82 CYP1A1 (0.61)
SCHEMBL29564492 0.78 KCNH2 (0.43)
SCHEMBL6833613 0.77 MAOB (0.53)
SCHEMBL27968638 0.77 FYN (0.37)
SCHEMBL3940185 0.76 PIK3CD (0.46)
SCHEMBL5591851 0.76 TP53 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 600 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240092773-A1 DIHYDRO-CYCLOPENTA-ISOQUINOLINE SULFONAMIDES DERIVATIVES UCB Biopharma SRL (BE) 2024-03-21 US claimed
US-20230192646-A1 DIHYDRO-CYCLOPENTA-ISOQUINOLINE DERIVATIVES UCB Biopharma SRL (BE) 2023-06-22 US claimed
EP-4081299-A1 DIHYDRO-CYCLOPENTA-ISOQUINOLINE DERIVATIVES UCB Biopharma SRL (BE) 2022-11-02 EP claimed
CN-114867525-A Dihydrocyclopentaisoquinoline derivatives UCB生物制药有限责任公司 2022-08-05 CN claimed
WO-2021130255-A1 DIHYDRO-CYCLOPENTA-ISOQUINOLINE DERIVATIVES UCB Biopharma SRL (BE) 2021-07-01 WO claimed
WO-2021130257-A1 DIHYDRO-CYCLOPENTA-ISOQUINOLINE SULFONAMIDES DERIVATIVES UCB Biopharma SRL (BE) 2021-07-01 WO claimed
CN-107311923-A A kind of synthetic method of the methoxypyridine of 3 iodine 5 康化(上海)新药研发有限公司 2017-11-03 CN claimed
US-20130331370-A1 CERTAIN KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF WITYAK JOHN (US) 2013-12-12 US claimed
WO-2010017179-A1 CERTAIN KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF CHDI, INC. (US) 2010-02-11 WO claimed
CN-1043717-A Cephalosporin compound TANABE SEIYAKU CO (JP) 1990-07-11 CN claimed
US-20260124222-A1 ISOTHIAZOLYLCARBOXAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS INC (US) 2026-05-07 US disclosed
EP-4034094-B1 PHOSPHODIESTERASE INHIBITORS AND USE ZENSHINE PHARMACEUTICALS NANJING GROUP CO LTD (CN) 2026-04-15 EP disclosed
EP-4294804-B1 PYRIDONE COMPOUNDS AND METHODS OF USE EXELIXIS INC (US) 2026-04-08 EP disclosed
US-20260092045-A1 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION 2026-04-02 US disclosed
EP-4713323-A1 3-CARBONYL IMIDAZO[1,5-A]PYRIDINE DERIVATIVES FOR USE AS CD38 INHIBITORS FOR THE TREATMENT OF CNS DISORDERS Cerevance, Inc. (US) 2026-03-25 EP disclosed
CN-1043717-A Cephalosporin compound TANABE SEIYAKU CO (JP) 1990-07-11 CN disclosed
EP-0333185-A2 Cyan dye-forming coupler and silver halide photosensitive material containing the same FUJI PHOTO FILM CO., LTD. (JP) 1989-09-20 EP disclosed
US-4229267-A Alkaline bright zinc plating and additive therefor RICHARDSON CHEMICAL COMPANY (US) 1980-10-21 US disclosed
US-4081336-A NITROGEN HETEROCYCLIC COMPOUND ALKYLATED WITH A CONDENSATE OF A DIFUNCTIONAL HALOHYDRIN, HYDROXYARYL COMPOUND, POLYETHYLENEPOLYAMINE THE RICHARDSON COMPANY (US) 1978-03-28 US disclosed
US-3972789-A HETEROCYCLIC-EPIHALOHYDRIN CONDENSATE THE RICHARDSON COMPANY (US) 1976-08-03 US disclosed